Articles related to Clinical Pharmacology

Mental health care professionals who prescribe or dispense to patients need to know the half-lives of the drugs that they prescribe, the half-lives of active metabolites — if any — how these half-lives may differ with individual patient characteristics, and how to use this knowledge to prescribe to best advantage.

This summary of a study from Johns Hopkins University says it might just matter how you take your pills – with special implications for bedridden or sedentary patients.

Here’s everything you could possibly want to know about “magic” mushrooms, including their short- and long-term effects on people, risks, history, and much more.

1.0 AMA PRA Category 1 Credit™1.0 ACPE contact hour (0.1 CEU) Release Date: May 1, 2022Expiration Date: May 1, 2023 Learning ObjectivesAfter completing this activity, participants should be better able to: Describe the pharmacologic and safety differences between conventional and atypical opioids. Recognize appropriate patients who might benefit from buprenorphine as a first-line opioid analgesic. Understand how to transition opioid therapy from full µ-opioid analgesics to buprenorphine when appropriate.

The greatest method to guarantee the best possible patient care, according to leaders of specialty pharmacies housed in health systems, is to supply specialized pharmaceuticals through the framework of a health system. It may be debatable which paradigm—the conventional standalone specialty pharmacies or the integrated model of health systems—is the best. However, it cannot be denied that a growing proportion of medications on the market are being introduced as specialty drugs.

Despite sufficient resources available to help practitioners make the right decisions about prescribing nirmatrelvir-ritonavir to the patients who may benefit, there are, without a doubt, instances when not prescribing nirmatrelvir-ritonavir is completely justified.